Valneva SE
NASDAQ:VALNBiotechnology
+$0.01 today
- Market cap
- $507.98M
- Beta
- 1.40
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.80
Volume 0.00M
Average 0.09M
VALN Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Valneva SENASDAQ: VALN
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of €252K (cash outflow) fell 82.9% year over year, ahead of the -83.6% change in trailing-twelve-month capital expenditures. Sequentially, it fell 79.8% from the prior quarter. Over 3 fiscal years it compounded at -46.5% a year.
Context
- Capital expenditures amounted to 2.6% of revenue in FY2025, down 7.1 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -82.9% holds above the trailing-twelve-month pace of -83.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
EUR · from the cash flow
- Latest · FY2025
- (4.48M) EUR
- Year-over-year change
- +72.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.48M) | +72.7% |
| FY2024 | 2024-12-31 | (16.44M) | -14.9% |
| FY2023 | 2023-12-31 | (14.31M) | +51.2% |
| FY2022 | 2022-12-31 | (29.32M) | +68.5% |
| FY2021 | 2021-12-31 | (93.17M) | — |
Capital Expenditures vs competitors
How VALN compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -83.6% is the lowest of 8, against a peer median of -41.5%.
- Capital expenditures amounts to 2.2% of revenue for VALN, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $185M USD | -73.0% | -21.7% | 7.3% | |
| LTM Jun 2026 | $40.64M USD | -46.1% | +32.9% | — | |
| LTM Sep 2026 | $9.53M USD | +87.3% | -63.4% | 5.2% | |
| LTM Mar 2026 | $5.61M USD | -37.6% | -60.9% | 0.9% | |
| LTM Mar 2026 | €3.42M EUR | -83.6% | -46.5% | 2.2% | |
| LTM Mar 2026 | $1.24M USD | +117.6% | -58.6% | 1.9% | |
| LTM Mar 2026 | $318.66K USD | -41.5% | -69.0% | 0.7% | |
| LTM Mar 2026 | $226.33K USD | -55.8% | -33.4% | — | |
| Peer median (excluding VALN) | — | -41.5% | -58.6% | 1.9% | |
Competitors are the stored peer set for VALN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (73.43M) | (143.28M) | (101.43M) | (12.25M) | (115.19M) |
| Depreciation & Amortization | 14.28M | 21.04M | 17.58M | 19.59M | 21.75M |
| Deferred Income Tax | 3.45M | (1.54M) | 2.8M | 761K | 1.07M |
| Stock-Based Compensation | 14.51M | (8.66M) | 5.11M | 7.98M | 9.53M |
| Change in Working Capital | 36.13M | (145.98M) | (145.06M) | (11.57M) | (148K) |
| Accounts Receivables | (21.35M) | 12.4M | (2.86M) | 15.71M | 13.33M |
| Inventory | (92.37M) | 84.22M | (9.17M) | (6.8M) | 1.03M |
| Accounts Payables | 35.24M | (14.05M) | (17.4M) | 0 | 0 |
| Other Working Capital | 114.61M | (228.55M) | (115.65M) | (20.48M) | (14.51M) |
| Other Non-Cash Items | 81.96M | 33.07M | 18.25M | (71.72M) | 30.09M |
| Operating Cash Flow | 76.9M | (245.34M) | (202.74M) | (67.22M) | (52.89M) |
| Capital Expenditures | (93.17M) | (29.32M) | (14.31M) | (16.44M) | (4.48M) |
| Acquisitions (Net) | 0 | 8K | (10.95M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 841K |
| Other Investing Activities | 55K | 260K | 4.6M | 90.78M | 1.87M |
| Investing Cash Flow | (93.12M) | (29.05M) | (20.59M) | 76.92M | (1.71M) |
| Debt Repayment | (3.9M) | 34.49M | 75.89M | (6.49M) | 61K |
| Common Stock Issued | 166.82M | 189.84M | 0 | 0 | 30M |
| Common Stock Repurchased | 0 | 0 | (240K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.42M) | (9.21M) | (12.57M) | (19.97M) | (30.69M) |
| Financing Cash Flow | 154.5M | 215.12M | 63.08M | 30.68M | (621K) |
| Effect of Forex Changes | 3.96M | (828K) | (204K) | 1.81M | (3.4M) |
| Net Change in Cash | 142.29M | (57.21M) | (160.45M) | 42.19M | (58.62M) |
| Free Cash Flow | (16.27M) | (274.67M) | (217.06M) | (83.66M) | (57.38M) |
Valneva SE
NASDAQ:VALN
Intrinsic Alpha fair value
Locked
Current Price
$5.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.